Affluent Medical today announced the successful first-in-human implant of its minimally invasive urinary incontinence treatment device.

Applied during endoscopic procedures, GastroShield could help prevent complications such as bleeding and leakage from weakened gastrointestinal tissues.

With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.